Laboratory methods for studying the role of eicosanoids in inflammatory bowel disease

  • N. K. Boughton-Smith
  • B. J. R. Whittle
Part of the Advances in Eicosanoid Research book series (AEIR, volume 2)


Since Gould first described an increase in the level of prostaglandin-like substances in the faeces of patients with active ulcerative colitis1, considerable research work has centred on the role of prostaglandins and other eicosanoids in inflammatory bowel disease (IBD). The results of these studies have been considered elsewhere in this book. The present chapter describes the laboratory methods that have been used to study the role of eicosanoids in IBD.


High Performance Liquid Chromatography Inflammatory Bowel Disease Arachidonic Acid Thin Layer Chromatography Ulcerative Colitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gould, S.R. (1976). Assay of prostaglandin-like substances in faeces and their measurement in ulcerative colitis. Prostaglandins, 11, 489–493PubMedCrossRefGoogle Scholar
  2. 2.
    Flower, R.J. (1978). Steroidal anti-inflammatory drugs as inhibitors of phospholipase A2. In Samuelsson, B. and Paoletti, R. (eds.) Adv. Prostagl. Thromhox. Res., 3, 105–112 (New York: Raven Press)Google Scholar
  3. 3.
    Higgs, G.A., Moncada, S. and Vane, J.R. (1984). Eicosanoids in inflammation. Ann. Clin. Res., 16, 287–299PubMedGoogle Scholar
  4. 4.
    Higgs, G.A., Palmer, R.M.J., Eakins, K.E. and Moncada, S. (1981). Arachidonic acid metabolism as a source of inflammatory mediators and its inhibition as a mechanism of action for anti-inflammatory drugs. Mol. Aspects Med., 4, 275–301CrossRefGoogle Scholar
  5. 5.
    Salmon, J.A. and Flower, R.J. (1983). Prostaglandins and related compounds. In Gray, C.H. and James, V.H.T. (eds.) Hormones in the Blood, Vol. 5, pp. 138–165. (Academic Press)Google Scholar
  6. 6.
    Whittle, B.J.R. and Vane, J.R. (1983). Prostacyclin, thromboxanes, and prostaglandins-actions and roles in the gastrointestinal tract. In Jerzy-Glass, G.B. and Sherlock, P. (eds.) Progress in Gastroenterology, pp. 3–30. (New York: Grune and Stratton)Google Scholar
  7. 7.
    Rask-Madsen, J. and Bukhave, K. (1979). Prostaglandins and chronic diarrhoea: clinical aspects. Scand. J. Gastroenterol., 14, Suppl. 53, 73–78Google Scholar
  8. 8.
    Rachmilewitz, D. (1980). Prostaglandins and diarrhoea. Dig. Dis. Sci., 25, 897–899PubMedCrossRefGoogle Scholar
  9. 9.
    Samuelsson, B., Borgeat, P., Hammarstrom, S. and Murphy, R.C. (1980). Leukotrienes: a new group of biologically active compounds. In Samuelsson, B., Ramwell, P. and Paoletti, R. (eds.) Adv. Prostagl. Thromhox. Res., 6, 1–18, (New York: Raven Press)Google Scholar
  10. 10.
    Samuelsson, B. (1983). Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science, 220, 568–575PubMedCrossRefGoogle Scholar
  11. 11.
    Rampton, D.S. and Hawkey, C.J. (1984). Prostaglandins and ulcerative colitis. Gut, 25, 1399–1413PubMedCrossRefGoogle Scholar
  12. 12.
    Gould, S.R., Brash, A.R., Conolly, M.E. and Lennard-Jones, J.E. (1981). Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostagl. Med., 6, 165–182CrossRefGoogle Scholar
  13. 13.
    Harris, D.W., Swan, C.H.J. and Smith, P.R. (1978). Venous prostaglandin-like activity in diarrhoeal states. Gut, 19, 1057–1058PubMedCrossRefGoogle Scholar
  14. 14.
    Rampton D.S., Sladen G.E. and Youlten, L.J. (1980). Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis. Gut, 21, 591–596PubMedCrossRefGoogle Scholar
  15. 15.
    Lauritsen, K., Laursen, L.S., Bukhave, K. and Rask-Madsen, J. (1985). Effects of topical 5-aminosalicylic acid (5-ASA) and prednisolone on prostaglandin (PG) E2 and leukotriene (LT) B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis (UC). Gastroenterology, 88, A1466Google Scholar
  16. 16.
    Eastwood, G.L. and Trier, J.R. (1973). Organ culture of human rectal mucosa. Gastroenterology, 64, 375–382PubMedGoogle Scholar
  17. 17.
    Eastwood, G.L. and Trier, J.R. (1973). Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis. Gastroenterology, 64, 383–390PubMedGoogle Scholar
  18. 18.
    Sharon, P., Ligumsky, M., Rachmilewitz, D. and Zor, U. (1978). Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology, 75, 638–649PubMedGoogle Scholar
  19. 19.
    Ligumsky, M., Karmeli, F., Sharon, P., Zor, U., Cohen, F. and Rachmilewitz, D. (1981). Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology, 81, 444–449PubMedGoogle Scholar
  20. 20.
    Hawkey, C.J. and Truelove, S.C. (1981). Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay. Gut, 22, 190–193PubMedCrossRefGoogle Scholar
  21. 21.
    Hawkey, C.J. and Truelove, S.C. (1983). Inhibition of prostaglandin synthetase in human rectal mucosa. Gut, 24, 213–217PubMedCrossRefGoogle Scholar
  22. 22.
    Hoult, J.R.S. and Page, J. (1981). 5-Aminosalicylic acid, a co-factor for colonic prostacyclin synthesis? Lancet, 1, 255CrossRefGoogle Scholar
  23. 23.
    Whittle, B.J.R. (1981). Temporal relationship between cyclo-oxygenase inhibition, measured as prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in rat. Gastroenterology, 80, 94–98PubMedGoogle Scholar
  24. 24.
    Sinzinger, H., Silberbrauer, K. and Seyfried, H. (1979). Rectal mucosa prostacyclin formation in ulcerative colitis. Lancet, 1, 444PubMedCrossRefGoogle Scholar
  25. 25.
    Harris, D.W., Smith, P.R. and Swan, C.H.J. (1978). Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease. Gut, 19, 875–877PubMedCrossRefGoogle Scholar
  26. 26.
    Boughton-Smith, N.K., Hawkey, C.J. and Whittle, B.J.R. (1983). Biosynthesis of lipoxygenase and cyclo-oxygenase products of [14C]-arachidonic acid by human colonic mucosa. Gut, 24, 1176–1182PubMedCrossRefGoogle Scholar
  27. 27.
    Vane, J.R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature, 231, 232–235Google Scholar
  28. 28.
    Higgs, G.A., Flower, R.J. and Vane, J.R. (1979). A new approach to anti-inflammatory drugs. Biochem. Pharmacol., 28, 1959–1961PubMedCrossRefGoogle Scholar
  29. 29.
    Sharon, P. and Stenson, W.F. (1984). Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology, 86, 453–460PubMedGoogle Scholar
  30. 30.
    Zifroni, A., Treves, A.J., Sachar, D.B. and Rachmilewitz, D. (1983). Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease. Gut, 24, 659–664PubMedCrossRefGoogle Scholar
  31. 31.
    Schlenker, T. and Peskar, B.M. (1981). Dual effect of sulphasalazine in colonic prostaglandin synthetase. Lancet, 1, 815CrossRefGoogle Scholar
  32. 32.
    Hoult, J.R.S. and Moore, P.K. (1978). Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis. Br. J. Pharmacol., 64, 6–8PubMedGoogle Scholar
  33. 33.
    Hillier, K., Mason, P.J., Pacheco, S. and Smith, C.L. (1982). Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro. Br. J. Pharmacol., 76, 157–161PubMedGoogle Scholar
  34. 34.
    Peskar, B.M., Dreyling, K.W., Hope, U., Schaavschmidt, K., Goebell, H. and Peskar, B.A. (1985). Formation of sulfidopeptide-leukotrienes (SP-LT) in normal human colonic tissue, colonic carcinoma and Crohn’s disease. Gastroenterology, 88, A1537Google Scholar
  35. 35.
    Hawkey, C.J., Boughton-Smith, N.K. and Whittle, B.J.R. (1985). Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig. Dis. Sci., 30, 1161–1165PubMedCrossRefGoogle Scholar
  36. 36.
    Borgeat, P. and Samuelsson, B. (1979). Arachidonic acid metabolism in polymorphonuclear leukocytes: effect of ionophore A23187. Proc. Natl. Acad. Sci., 76, 2148–2152PubMedCrossRefGoogle Scholar
  37. 37.
    Bennett, A., Hensby, C.N., Sanger, G.J. and Stamford, I.F. (1981). Metabolites of arachidonic acid formed by human gastrointestinal tissues and their actions on the muscle layers. Br. J. Pharmacol., 74, 435–444PubMedGoogle Scholar
  38. 38.
    Aly, A., Johansson, C., Slezak, P. and Green, K. (1984). Bioconversion of arachidonic acid in the human gastrointestinal tract. Biochem. Med., 31, 319–331PubMedCrossRefGoogle Scholar
  39. 39.
    Turk, J., Maas, R.L., Brash, A.R., Jackson Roberts, L. and Oates, J.A. (1982). Arachidonic acid 15-lipoxygenase products from human eosinophils. J. Biol. Chem., 257, 7068–7076PubMedGoogle Scholar
  40. 40.
    Harkness, R.A. (1981). The characteristic cell of acute inflammation, the polymorphonuclear neutrophil leucocyte, and its biochemistry. Molec. Aspects Med., 4, 191–207CrossRefGoogle Scholar
  41. 41.
    Schultz, J. and Kaminker, K. (1962). Myeloperoxidase of the leukocyte of normal blood content and localization. Arch. Biochem. Biophys., 96, 456–467CrossRefGoogle Scholar
  42. 42.
    Bradley, P.P., Priebat, D.A., Christensen, R.D. and Rothstein, G. (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol., 78, 206–209PubMedCrossRefGoogle Scholar
  43. 43.
    Williams, R.N. and Paterson, C.A. (1985). Anomalous effects of anti-inflammatory corticosteroids in endotoxin-induced ocular inflammation. Eur. J. Pharmacol., 106, 113–119CrossRefGoogle Scholar
  44. 44.
    Mullane, K.M., Fraemer, R. and Smith, B. (1985). Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischaemic myocardium. J. Pharmacol. Meth., 14, 157–167CrossRefGoogle Scholar
  45. 45.
    Krawisz, J.E., Sharon, P. and Stenson, W.F. (1984). Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology, 87, 1344–1350PubMedGoogle Scholar
  46. 46.
    Boughton-Smith, N.K., Wallace, J.L. and Whittle, B.J.R. (1985). Arachidonic acid metabolism and leukocyte infiltration, as measured by myeloperoxidase activity in a model of IBD. Gut, 26, A1148Google Scholar
  47. 47.
    O’Morain, C., Smethhurst, P., Levi, A.J. and Peters, T.J. (1983). Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn’s disease. J. Clin. Pathol., 36, 1312–1316PubMedCrossRefGoogle Scholar
  48. 48.
    Seymour, C.A. and Peters, T.J. (1977). Enzyme activities in human liver biopsies. Assay methods and activities of some lysosomal and membrane-bound enzyme in control tissue samples. Clin. Sci. Mol. Med., 52, 229–239PubMedGoogle Scholar
  49. 49.
    Kane, S.P. and Peters, T.J. (1975). Analytical subcellular fractionation of human granulocytes with reference to the localisation of vitamin B12 binding protein. Clin. Sci. Mol. Med., 49, 171–182PubMedGoogle Scholar
  50. 50.
    Rachmilewitz, D., Ligumsky, M., Rachmilewitz, B., Rachmilewitz, M., Tarcic, N. and Schlesinger, M. (1980). Transcobalomin II level in peripheral blood monocytes — a biochemical marker in inflammatory bowel disease. Gastroenterology, 78, 43–46PubMedGoogle Scholar
  51. 51.
    Flemming, A. (1922). On a remarkable bacteriolytic element found in tissues and secretions. Proc. Roy. Soc. B, 93, 306–312CrossRefGoogle Scholar
  52. 52.
    Lippman, M.F. and Finch, S.C. (1972). A quantitative study of muramidase distribution in normal and nitrogen mustard treated rats. Yale J. Biol. Med., 45, 463–470PubMedGoogle Scholar
  53. 53.
    MacPherson, B. and Pfeiffer, C.J. (1976). Experimental colitis. Digestion, 14, 424–452PubMedCrossRefGoogle Scholar
  54. 54.
    Madara, J.L., Podolsky, D.K., King, N.W., Sehgal, P.K., Moore, R. and Winter, H.S. (1985). Characterization of spontaneous colitis in cotton-top tamarins (saguinus oedipus) and its response to sulfasalazine. Gastroenterology, 88, 13–19PubMedGoogle Scholar
  55. 55.
    Marston, A., Marcuson, R.W., Chapman, M. and Arthur, J.E. (1969). Experimental study of devascularization of the colon. Gut, 10, 121–130PubMedCrossRefGoogle Scholar
  56. 56.
    Kirsner, J.B. (1961). Experimental ‘colitis’ with particular reference to hypersensitivity reactions in the colon. Gastroenterology, 40, 307–312PubMedGoogle Scholar
  57. 57.
    Pfeiffer, C.J. (1985). Animal models of colitis. In Pfeiffer, C.J. (ed.) Animal Models of Intestinal Disease, pp. 148–155. (Florida: CRC Press)Google Scholar
  58. 58.
    Halpern, B., Zweibaum, A., Oriol Palou, R. and Morard, J.C. (1967). Experimental immune ulcerative colitis. In Immunopathology. 5th Int. Symp. Mechanisms of Inflammation induced by Immune Reactions. pp. 161–178. (New York: Grune and Stratton)Google Scholar
  59. 59.
    Cooke, E.M., Filipe, M.T. and Dawson, I.M.P. (1968). The production of colonic autoantibodies in rabbits by immunization with Escherichia coli. J. Pathol. Bacterial., 96, 125–130CrossRefGoogle Scholar
  60. 60.
    Rabin, B.S. and Herrington, E. (1980). Antibody-mediated complement-dependent cytotoxicity in immunologically induced experimental colon disease. Int. Arch. Allergy Immun., 63, 205–211CrossRefGoogle Scholar
  61. 61.
    Kraft, S.C. and Kirsner, J.B. (1971). Immunological apparatus of the gut and inflammatory bowel disease. Gastroenterology, 60, 922–951PubMedGoogle Scholar
  62. 62.
    Humphrey, C.D., Lushbaugh, W.B., Condon, C.W., Pittman, J.C. and Pittman, F.E. (1979). Light and electron microscopic studies of antibiotic associated colitis in the hamster. Gut, 20, 6–15PubMedCrossRefGoogle Scholar
  63. 63.
    Rehg, J.E. (1980). Cecal toxin(s) from guinea pigs with clindamycin-associated colitis, neutralized by Clostridium sordellii antitoxin. Infect. Immun., 27, 387–390PubMedGoogle Scholar
  64. 64.
    Rothman, S.W. (1981). Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis. Med. Microbiol. Immunol., 169, 187–196PubMedCrossRefGoogle Scholar
  65. 65.
    Melnyk, C.S. (1980). Experimental enteritis and colitis. In Kirsner, J.B. and Shorter, R.G. (eds.) Inflammatory Bowel Disease, pp. 25–43 (Philadelphia: Lea and Febiger)Google Scholar
  66. 66.
    Kirsner, J.B., Elahlepp, J.G., Goldgraber, M.B., Ablaza, J. and Ford, H. (1959). Production of experimental ulcerative ‘colitis’ in rabbits. Arch. Pathol., 68, 392–408PubMedGoogle Scholar
  67. 67.
    Hodgson, H.J.F., Potter, B.J., Skinner, J. and Jewell, D.P. (1978). Immune-complex mediated colitis in rabbits. Gut, 19, 225–232PubMedCrossRefGoogle Scholar
  68. 68.
    Mee, A.S., McLaughlin, J.E., Hodgson, H.J.F. and Jewell, D.P. (1979). Chronic immune colitis in rabbits. Gut, 20, 1–5PubMedCrossRefGoogle Scholar
  69. 69.
    Marcus, R. and Watt, J. (1969). Seaweeds and ulcerative colitis in laboratory animals. Lancet, 2, 489–490PubMedCrossRefGoogle Scholar
  70. 70.
    Watt, J. and Marcus, R. (1971). Carrageenan-induced ulceration of the large intestine in the guinea pig. Gut, 12, 164–171PubMedCrossRefGoogle Scholar
  71. 71.
    Watt, J., McLean, C. and Marcus, R. (1979). Degradation of carrageenan for the experimental production of ulcers in the colon. J. Pharm. Pharmacol., 31, 645–646PubMedCrossRefGoogle Scholar
  72. 72.
    Benitz, K.-F., Goldberg, L. and Coulston, F. (1973). Intestinal effects of carrageenans in the rhesus monkey. Food Cosmet. Toxicol., 11, 565–575PubMedCrossRefGoogle Scholar
  73. 73.
    Grasso, P., Sharratt, M., Carpanini, F.M.B. and Gangolli, S.D. (1973). Studies on carrageenan and large-bowel ulceration in mammals. Food Cosmet. Toxicol., 11, 555–564PubMedCrossRefGoogle Scholar
  74. 74.
    Norris, A.A., Lewis, A.J. and Zeitlin, I.J. (1981). Inability of degraded carrageenan fractions to induce inflammatory bowel ulceration in the guinea-pig. J. Pharm. Pharmacol., 33, 612–613PubMedCrossRefGoogle Scholar
  75. 75.
    Boxenbaum, H.G. and Dairman, W. (1977). Evaluation of an animal model for the screening of compounds potentially useful in human ulcerative colitis: effect of salicylazosulfapyridine and prednisolone on carrageenan-induced ulceration of the large intestine of the guinea pig. Drug Dev. Ind. Pharm., 3, 121–130CrossRefGoogle Scholar
  76. 76.
    Watt, J., Marcus, S.N. and Marcus, A.J. (1980). The comparative prophylactic effects of sulphasalazine, prednisolone and azathioprine in experimental colonic ulceration. J. Pharm. Pharmacol., 32, 873–874PubMedCrossRefGoogle Scholar
  77. 77.
    Jensen, B.H., Andersen, J.O., Poulsen, S.S., Skov Olsen, P., Norby, S., Rasmussen, S., Hansen, H. and Hvidberg, E.F. (1984). The prophylactic effect of 5-aminosalicylic acid and salazosulphapyridine on degraded-carrageenan-induced colitis in guinea pigs. Scand. J. Gastroenterol., 19, 299–303PubMedGoogle Scholar
  78. 78.
    Onderdonk, A.B., Hermos, J.A., Dzink, J.L. and Bartlett, J.L. (1978). Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology, 74, 521–526PubMedGoogle Scholar
  79. 79.
    Onderdonk, A.B. and Bartlett, J.G. (1979). Bacteriological studies of experimental ulcerative colitis. Am. J. Clin. Nutr., 32, 258–265 PubMedGoogle Scholar
  80. 80.
    Rosenberg, E.W. and Fischer, R.W. (1964). DNCB allergy in the guinea pig colon. Arch. Dermatol., 89, 159–163CrossRefGoogle Scholar
  81. 81.
    Bicks, R.O., Azar, M.M., Rosenberg, E.W., Dunham, W.G. and Luther, J. (1967). Delayed hypersensitivity reactions in the intestinal tract. I. Studies of 2,4-dinitrochlorobenzene-caused guinea pig and swine colon lesions. Gastroenterology, 53, 422–436Google Scholar
  82. 82.
    Rabin, B.S. and Rogers, S.J. (1978). A cell-mediated immune model of inflammatory bowel disease in the rabbit. Gastroenterology, 75, 29–33PubMedGoogle Scholar
  83. 83.
    Glick, M.E. and Falchuk, Z.M. (1981). Dinitrochlorobenzene-induced colitis in the guineapig: studies of colonic lamina propria lymphocytes. Gut, 22, 120–125PubMedCrossRefGoogle Scholar
  84. 84.
    Askenase, P.W., Boone, W.T. and Binder, H.J. (1978). Colonic basophil hypersensitivity. J. Immunol., 120, 198–201PubMedGoogle Scholar
  85. 85.
    Mitchell, E.B. and Askenase, P.W. (1982). Suppression of T cell-mediated cutaneous basophil hypersensitivity by serum from guinea-pigs immunized with mycobacterial adjuvant. J. Exp. Med., 156, 159–172PubMedCrossRefGoogle Scholar
  86. 86.
    Norris, A.A., Lewis, A.J. and Zeitlin, I.J. (1982). Changes in colonic tissue levels of inflammatory mediators in a guinea-pig model of immune colitis. Agents Actions, 12, 243–246PubMedCrossRefGoogle Scholar
  87. 87.
    Boughton-Smith, N.K. and Whittle, B.J.R. (1985). Increased metabolism of arachidonic acid in an immune model of colitis in guinea-pigs. Br. J. Pharmacol., 86, 439–446PubMedGoogle Scholar
  88. 88.
    Salmon, J.A., Simmons, P.M. and Palmer, R.M.J. (1982). A radioimmunoassay for leukotriene B4. Prostaglandins, 24, 225–235PubMedCrossRefGoogle Scholar
  89. 89.
    Hoult, J.R.S., Moore, P.K., Marcus, A.J. and Watt, J. (1979). On the effect of sulphasalazine on the prostaglandin system and the defective prostaglandin inactivation observed in experimental ulcerative colitis. Agents Actions, 4, 232–244Google Scholar
  90. 90.
    Wolbling, R.H., Aehringhaus, U., Peskar, B.A., Morgenroth, K. and Peskar, B.M. (1983). Release of slow-reacting substance of anaphylaxis and leukotriene C4-like immunoreactiv-ity from guinea pig colonic tissue. Prostaglandins, 25, 809–822PubMedCrossRefGoogle Scholar
  91. 91.
    Zipser, R.D., Patterson, J.B., Kao, H.W., Hauser, C.J. and Lecke, R. (1985). Hypersensitive prostaglandin and thromboxane response to hormones in rabbit colitis. Am. J. Physiol., 249, G457–G463PubMedGoogle Scholar
  92. 92.
    Sharon, P. and Stenson, W.F. (1985). Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease. Gastroenterology, 88, 55–63PubMedGoogle Scholar
  93. 93.
    Morris, G.P., Rebetro, L., Herridge, M.M., Szewczuk, M. and Depew, W. (1984). An animal model for chronic granulomatous inflammation of the stomach and colon. Gastroenterology, 86, A1188Google Scholar
  94. 94.
    Robert, A. (1976). Antisecretory anti-ulcer, cytoprotective and diarrheogenic properties of prostaglandins. In Samuelsson, R. and Paoletti, R. (eds.) Adv. Prostagl. Thrombox. Res., 2, 507–520. (New York: Raven Press)Google Scholar
  95. 95.
    Miller, T.A. (1983). Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanism. Am. J. Physiol., 254, G601–G623Google Scholar
  96. 96.
    Hawkey, C.J. and Rampton, D.S. (1985). Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology, 89, 1162–1188PubMedGoogle Scholar
  97. 97.
    Robert, A. (1975). An intestinal disease produced experimentally by a prostaglandin deficiency. Gastroenterology, 69, 1045–1047PubMedGoogle Scholar
  98. 98.
    Lancaster, C. and Robert, A. (1978). Intestinal lesions produced by prednisolone: Prevention (cytoprotection) by 16,16-dimethyl prostaglandin E2. Am. J. Physiol., 235, E703–E708PubMedGoogle Scholar
  99. 99.
    Robert, A., Bundy, G.L., Field, S.O., Nezamis, J.E., Davis, J.P., Hanchar, A.J., Lancaster, C. and Ruwart, M.J. (1985). Prevention of colitis in hamsters by certain prostaglandins. Prostaglandins, 29, 961–980PubMedCrossRefGoogle Scholar
  100. 100.
    Whittle, B.R.J. and Boughton-Smith, N.K. (1979). 16-Phenoxy prostacyclin analogs-potent selective antiulcer compounds. In Vane, J.R. and Bergstrom, S. (eds.) Prostacyclin, pp. 159–170. (New York: Raven Press)Google Scholar
  101. 101.
    Wallace, J.L., Whittle, B.J.R. and Boughton-Smith, N.K. (1985). Prostaglandin protection of rat colonic mucosa from damage induced by ethanol. Dig. Dis. Sci., 30, 866–876PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1988

Authors and Affiliations

  • N. K. Boughton-Smith
  • B. J. R. Whittle

There are no affiliations available

Personalised recommendations